Phase II Study of Concurrent Lenvatinib and Radiotherapy for Advanced HCC
Clinical trial NCT04791176 · COMPLETED
Trial details
- NCT number
- NCT04791176
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-12
- Primary completion
- 2024-06-30
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.